María Ángeles Goñi

Early prediction of subsequent molecular response to nilotinib in patients with chronic myeloid leukemia: Comparison of the quantification of BCR-ABL1 ratios using ABL1 or GUSB control genes.

D. Colomer, F. Sánchez-Guijo, L. Palomera, 2020, The Journal of molecular diagnostics : JMD.

Severe obesity in a patient on long-term treatment of chronic myeloid leukemia with imatinib: Body composition, associated disorders and outcome

J. Illarramendi, A. Zugasti, María Ángeles Goñi, 2021, Journal of Clinical Images and Medical Case Reports.